ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - Æxlishemjandi lyf - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies.  follicular lymphoma (fl) that is refractory to at least two prior  systemic therapies.

আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

essential pharma limited - haloperidolum dekanóat - stungulyf, lausn - 100 mg/ml

আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

essential pharma limited - haloperidolum inn - tafla - 1 mg

আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

essential pharma limited - haloperidolum inn - stungulyf, lausn - 5 mg/ml

আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

orion corporation - hydrocortisonum inn - tafla - 10 mg

ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

abbvie deutschland gmbh co. kg - lopinavir, rítónavír - hiv sýkingar - antivirals for systemic use, protease inhibitors - kaletra er ætlað ásamt öðrum antiretroviral lyf til meðferð hiv veira (hiv-1) sýkt fullorðnir, unglingum og börn á aldrinum 14 daga og eldri. val á kaletra að meðhöndla próteasahemla upplifað hiv-1 sýkt sjúklingar ætti að vera byggt á einstökum veiru mótstöðu próf og meðferð sögu af sjúklingum.

আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

alvogen ehf. - diclofenacum natríum - magasýruþolin tafla - 50 mg

আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

novartis healthcare a/s - everolimusum inn - tafla - 0,75 mg

আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

novartis healthcare a/s - everolimusum inn - tafla - 0,5 mg

আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

novartis healthcare a/s - everolimusum inn - tafla - 0,25 mg